Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy.
L BrilliR DanielliM CampanileC SecchiC CiuoliL CalabròT PilliA CartocciF PaciniA M Di GiacomoMaria Grazia CastagnaPublished in: Journal of endocrinological investigation (2020)
Pre-treatment serum TSH and ATAbs levels may help to identify patients at high risk for primary thyroid dysfunction. Our study suggests guidance for an appropriate timely screening and for a tailored management of thyroid dysfunctions in patients treated with ICIs.